Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol

Journal of Psychiatry and Neuroscience

Volumn 26, Issue 2, 2001, Pages 137-149

  Purdon, S E ^a   Malla, A ^a   Labelle, A ^a   Lit, W ^a  

^a ALBERTA HOSPITAL EDMONTON   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; CHLORAL HYDRATE; CLONAZEPAM; FLUPENTIXOL DECANOATE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; INSULIN; LORAZEPAM; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRIAMTERENE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; IMPOTENCE; MALE; MOOD; NAUSEA; NEGATIVE SYNDROME; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SOMNOLENCE; TREATMENT OUTCOME; VERBAL COMMUNICATION; VOMITING; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DECISION MAKING; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0035036143     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Positive and negative schizophrenia and their response to dopamine
2. The relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia
3. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
4. Cognitive improvement in schizophrenia with novel antipsychotic medications
5. Measuring neuropsychological change in schizophrenia with novel antipsychotic medications
6. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis
7. The effect of clozapine on cognition and psychiatric symptoms in patients with schizophrenia
8. Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenia patients receiving clozapine
9. The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance
10. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
11. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders
12. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia
13. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
14. Quetiapine in patients with schizophrenia: A high- and low-dose double-blind comparison with placebo
15. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidok
16. Cognitive function in schizophrenic patients
17. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
18. Effects of olanzapine on regional C-Fos expression in rat forebrain
19. Contrasting effects of chronic clozapine Seroquel™ (ICI 204,636) and haloperidol administration of delta FosB-like immunoreactivity in the rodent forebrain
20. Olanzapine and models of cognition
21. Seroquel and cognitive improvement in patients with schizophrenia
22. Attentional improvement following quetiapine fumarate treatment in schizophrenia
23. Cognitive improvement to clozapine
24. Neuropsychological change in schizophrenia with 6 weeks' clozapine
25. Abnormal Involuntary Movement Scale (AIMS)
26. A rating scale for extra-pyramidal side effects
27. Specificity of the Calgary Depression Scale for schizophrenics
28. Normative data on selected neuropsychological measures from a nonclinical sample
29. Clinical neuropsychology
30. Gender- and age-specific changes in motor speed and eye and coordination in adults: Normative values for the finger tapping and grooved pegboard tests
31. Design fluency: The invention of nonsense drawings after focal cortical lesions
32. Interrater reliability of scoring parameters for the Design Fluency Test
33. L'examen psychologique dans les cas d'encephalopathie traumatique
34. Psychological assessment of neurosurgical patients
35. Rey Complex Figure Test under four different administration procedures
36. Test-retest reliability of a new form of the Auditory Verbal Learning Test (AVLT)
37. A standardized memory scale for clinical use
38. Schizophrenia, memory, and anticholinergic drugs
39. Neurocognitive impairment in schizophrenia and how it affects treatment options
40. Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
41. The left striatopallidal hyperactivity model of schizophrenia
42. Cognitive dysfunction in schizophrenia: Comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs
43. Does risperidone improve verbal working memory in treatment-resistant schizophrenia?
44. What are the functional consequences of neurocognitive deficits in schizophrenia?